Glycosylation of sera thyroglobulin antibody in patients with thyroid diseases

European Journal of Endocrinology

Volumn 168, Issue 4, 2013, Pages 585-592

  Zhao, Lanlan ^a   Liu, Mingming ^a   Gao, Ying ^a   Huang, Youyuan ^a   Lu, Guizhi ^a   Gao, Yanming ^a   Guo, Xiaohui ^a   She, Bingyin ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FUCOSE; GALACTOSE; IMMUNOGLOBULIN G; SIALIC ACID; THYROGLOBULIN ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; LYMPHOCYTIC THYROIDITIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SIALYLATION; SUBCLINICAL HYPOTHYROIDISM; THYROID CARCINOMA; THYROID DISEASE;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; GLYCOSYLATION; HUMANS; MALE; MIDDLE AGED; THYROGLOBULIN; THYROID DISEASES; TIME FACTORS; YOUNG ADULT;

EID: 84875207902     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0964     Document Type: Article

References (39)

1. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA & Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism 2002 87 489-499. (doi:10.1210/jc.87.2.489)
2. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS & Nicoloff JT. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1998 83 1121-1127. (doi:10.1210/jc.83.4. 1121)
3. Calder EA, Penhale WJ, McLeman D, Barnes EW & Irvine WJ. Lymphocyte-dependent antibody-mediated cytotoxicity in Hashimoto thyroiditis. Clinical and Experimental Immunology 1973 14 153-158.
4. Spencer CA. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). Journal of Clinical Endocrinology and Metabolism 2011 96 3615-3627. (doi:10.1210/jc.2011-1740)
5. Torrigiani G, Roitt IM & Doniach D. Quantitative distribution of human thyroglobulin autoantibodies in different immunoglobulin classes. Clinical and Experimental Immunology 1968 3 621-630.
6. Lux A & Nimmerjahn F. Impact of differential glycosylation on IgG activity. Advances in Experimental Medicine and Biology 2011 780 113-124. (doi:10.1007/978-1-4419-5632-3-10)
7. Raju TS. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Current Opinion in Immunology 2008 20 471-478. (doi:10.1016/j.coi.2008.06.007)
8. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, Weikert SH & Presta LG. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. Journal of Biological Chemistry 2002 277 26733-26740. (doi:10.1074/jbc.M202069200)
9. Satoh M, Iida S & Shitara K. Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies. Expert Opinion on Biological Therapy 2006 6 1161-1173. (doi:10.1517/14712598.6.11.1161)
10. Scallon BJ, Tam SH, McCarthy SG, Cai AN & Raju TS. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Molecular Immunology 2007 44 1524-1534. (doi:10.1016/j.molimm. 2006.09.005)
11. Kaneko Y, Nimmerjahn F & Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006 313 670-673. (doi:10.1126/science.1129594)
12. Axford JS, Sumar N, Alavi A, Isenberg DA, Young A, Bodman KB & Roitt IM. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. Journal of Clinical Investigation 1992 89 1021-1031. (doi:10.1172/JCI115643)
13. Cremata JA, Sorell L, Montesino R, Garcia R, Mata M, Cabrera G, Galvan JA, Garcia G, Valdes R & Garrote JA. Hypogalactosylation of serum IgG in patients with coeliac disease. Clinical and Experimental Immunology 2003 133 422-429. (doi:10.1046/j.1365-2249.2003.02220.x)
14. Kanoh Y, Mashiko T, Danbara M, Takayama Y, Ohtani S, Egawa S, Baba S & Akahoshi T. Changes in serum IgG oligosaccharide chains with prostate cancer progression. Anticancer Research 2004 24 3135-3139.
15. Gercel-Taylor C, Bazzett LB & Taylor DD. Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer. Gynecologic Oncology 2001 81 71-76. (doi:10.1006/gyno.2000.6102)
16. Kodar K, Stadlmann J, Klaamas K, Sergeyev B & Kurtenkov O. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. Glycoconjugate Journal 2012 29 57-66. (doi:10.1007/s10719-011-9364-z)
17. Keusch J, Levy Y, Shoenfeld Y & Youinou P. Analysis of different glycosylation states in IgG subclasses. Clinica Chimica Acta 1996 252 147-158. (doi:10.1016/0009-8981(96)06326-7)
18. Radziejewska I, Borzym-Kluczyk M, Kisiel DG, Namiot Z,Wosek J & Gindzienski A. Characterisation of glycoforms of ascitic fluids in benign and malignant diseases. Clinical Biochemistry 2009 42 72-77. (doi:10.1016/j. clinbiochem.2008.09.114)
19. Pasek M, Duk M, Podbielska M, Sokolik R, Szechinski J, Lisowska E & Krotkiewski H. Galactosylation of IgG from rheumatoid arthritis (RA) patients - changes during therapy. Glycoconjugate Journal 2006 23 463-471. (doi:10.1007/s10719-006-5409-0)
20. Mondal G, Chatterjee U, Chawla YK & Chatterjee BP. Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients. Glycoconjugate Journal 2011 28 1-9. (doi:10.1007/s10719-010-9316-z)
21. Endo T, Wright A, Morrison SL & Kobata A. Glycosylation of the variable region of immunoglobulin G - site specific maturation of the sugar chains. Molecular Immunology 1995 32 931-940. (doi:10.1016/0161-5890(95)00078-S)
22. Chen G,Wang Y, Qiu L, Qin X, Liu H,Wang X, Song G, Li F, Guo Y, Guo S et al. Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer. Journal of Proteomics 2012 75 2824-2834. (doi:10.1016/j.jprot.2012.02.001)
23. Wang J, Balog CI, Stavenhagen K, Koeleman CA, Scherer HU, Selman MH, Deelder AM, Huizinga TW, Toes RE & Wuhrer M. Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Molecular and Cellular Proteomics 2011 10 M110.004655. (doi:10.1074/mcp.M110.004655)
24. Weetman AP, McGregor AM, Lazarus JH & Hall R. Thyroid antibodies are produced by thyroid-derived lymphocytes. Clinical and Experimental Immunology 1982 48 196-200.
25. Ferrara C, Stuart F, Sondermann P, Brunker P & Umana P. The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. Journal of Biological Chemistry 2006 281 5032-5036. (doi:10.1074/jbc.M510171200)
26. Junttila TT, Parsons K, Olsson C, Lu Y, Xin Y, Theriault J, Crocker L, Pabonan O, Baginski T, Meng G et al. Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer. Cancer Research 2010 70 4481-4489. (doi:10.1158/0008-5472.CAN-09-3704)
27. Mori K, Iida S, Yamane-Ohnuki N, Kanda Y, Kuni-Kamochi R, Nakano R, Imai-Nishiya H, Okazaki A, Shinkawa T, Natsume A et al. Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies. Cytotechnology 2007 55 109-114. (doi:10.1007/s10616-007-9103-2)
28. Hodoniczky J, Zheng YZ & James DC. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnology Progress 2005 21 1644-1652. (doi:10.1021/bp050228w)
29. Weetman AP. Autoimmune thyroid disease. Autoimmunity 2004 37 337-340. (doi:10.1080/08916930410001705394)
30. Latrofa F, Ricci D, Grasso L, Vitti P, Masserini L, Basolo F, Ugolini C, Mascia G, Lucacchini A & Pinchera A. Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. Journal of Clinical Endocrinology and Metabolism 2008 93 591-596. (doi:10.1210/jc.2007-1199)
31. WuhrerM, PorcelijnL,Kapur R,KoelemanCA,Deelder A, deHaasM & Vidarsson G. Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. Journal of Proteome Research 2009 8 450-456. (doi:10.1021/pr800651j)
32. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F et al. The incidence of thyroid disorders in the community: a twentyyear follow-up of the Whickham Survey. Clinical Endocrinology 1995 43 55-68. (doi:10.1111/j.1365-2265.1995. tb01894.x)
33. Parekh R, Isenberg D, Rook G, Roitt I, Dwek R & Rademacher T. A comparative analysis of disease-associated changes in the galactosylation of serum IgG. Journal of Autoimmunity 1989 2 101-114. (doi:10.1016/0896-8411(89) 90148-0)
34. Chen CR, Hamidi S, Braley-Mullen H, Nagayama Y, Bresee C, Aliesky HA, Rapoport B & McLachlan SM. Antibodies to thyroid peroxidase arise spontaneously with age in NOD.H-2h4 mice and appear after thyroglobulin antibodies. Endocrinology 2010 151 4583-4593. (doi:10.1210/en.2010-0321)
35. Effraimidis G, Strieder TG, Tijssen JG & Wiersinga WM. Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. European Journal of Endocrinology 2011 164 107-113. (doi:10.1530/EJE-10-0785)
36. In Williams Textbook of Endocrinology, 11th edn, pp 324-390. Eds HM Kronenberg, S Melmed, KS Polonsky & PR Larsen. Philadelphia, PA: Saunders Publishers Limited, 2007.
37. Arnold JN, Wormald MR, Sim RB, Rudd PM & Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annual Review of Immunology 2007 25 21-50. (doi:10.1146/annurev.immunol.25. 022106.141702)
38. Kinoshita N, Ohno M, Nishiura T, Fujii S, Nishikawa A, Kawakami Y, Uozumi N & Taniguchi N. Glycosylation at the Fab portion of myeloma immunoglobulin G and increased fucosylated biantennary sugar chains: structural analysis by high-performance liquid chromatography and antibody-lectin enzyme immunoassay using Lens culinaris agglutinin. Cancer Research 1991 51 5888-5892.
39. Kiso Y, Furmaniak J, Morteo C & Smith BR. Analysis of carbohydrate residues on human thyroid peroxidase (TPO) and thyroglobulin (Tg) and effects of deglycosylation, reduction and unfolding on autoantibody binding. Autoimmunity 1992 12 259-269. (doi:10.3109/08916939209148468)